...
首页> 外文期刊>The Lancet >Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial
【24h】

Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial

机译:基于正念的认知疗法与维持性抗抑郁药在预防抑郁症复发或复发(PREVENT)方面的有效性和成本效益:一项随机对照试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background Individuals with a history of recurrent depression have a high risk of repeated depressive relapse or recurrence. Maintenance antidepressants for at least 2 years is the current recommended treatment, but many individuals are interested in alternatives to medication. Mindfulness-based cognitive therapy (MBCT) has been shown to reduce risk of relapse or recurrence compared with usual care, but has not yet been compared with maintenance antidepressant treatment in a definitive trial. We aimed to see whether MBCT with support to taper or discontinue antidepressant treatment (MBCT-TS) was superior to maintenance antidepressants for prevention of depressive relapse or recurrence over 24 months.
机译:背景患有复发性抑郁史的人反复抑郁复发或复发的风险很高。目前推荐的治疗方法是维持抗抑郁药至少2年,但许多人对替代药物感兴趣。与常规治疗相比,基于正念的认知疗法(MBCT)已被证明可以降低复发或复发的风险,但在最终的试验中尚未与维持抗抑郁药进行比较。我们旨在观察在逐渐减少或持续24个月内预防抑郁症复发或复发的情况下,MBCT支持减量或终止抗抑郁药治疗(MBCT-TS)是否优于维持性抗抑郁药。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号